| Name | Title | Contact Details |
|---|---|---|
Rajeev Ronanki |
Senior Vice President and Chief Digital Officer | Profile |
Jason Hall |
Director, Technology, Endpoint Security | Profile |
Brian Quick |
Staff Vice President Security Threat Management | Profile |
Matt Klein |
Senior Director of Information Security | Profile |
Matt Klein |
Senior Director of Information Security | Profile |
Behavioral Medical Research of Staten Island, PC is a Staten Island, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Century Healthcare provides functional solutions to help employers meet the challenges of today`s complex healthcare environment. We are an organization committed to the design, implementation and administration of customized benefit plans for employers of all sizes throughout the U.S.
Angela Hospice is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Southern California, Beachbody is a worldwide leading digital fitness and nutrition subscription company with over two decades of creating innovative content and powerful brands. The Beachbody Company is the parent company of the Beachbody On Demand streaming platform (BOD), the Openfit live digital streaming platform and MYXfitness, the Company`s connected fitness brand.
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.